IRIS
LORUSSO, BRUNO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.805
EU - Europa 1.494
AS - Asia 1.316
SA - Sud America 234
AF - Africa 73
OC - Oceania 5
Totale 4.927
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.745
IT - Italia 581
SG - Singapore 550
CN - Cina 371
IE - Irlanda 190
BR - Brasile 180
DE - Germania 142
SE - Svezia 130
HK - Hong Kong 123
VN - Vietnam 85
NL - Olanda 65
AT - Austria 61
FI - Finlandia 58
GB - Regno Unito 56
RU - Federazione Russa 47
FR - Francia 45
ZA - Sudafrica 41
IN - India 38
CA - Canada 36
BD - Bangladesh 34
TR - Turchia 24
AR - Argentina 22
CZ - Repubblica Ceca 21
BE - Belgio 20
PL - Polonia 20
CI - Costa d'Avorio 18
MX - Messico 18
IQ - Iraq 15
JP - Giappone 15
KR - Corea 12
UA - Ucraina 12
EC - Ecuador 11
ES - Italia 10
IR - Iran 10
LT - Lituania 8
PK - Pakistan 8
CO - Colombia 6
RO - Romania 6
AU - Australia 5
ID - Indonesia 5
LU - Lussemburgo 5
MA - Marocco 5
VE - Venezuela 5
AZ - Azerbaigian 4
IL - Israele 4
TN - Tunisia 4
BG - Bulgaria 3
EG - Egitto 3
GR - Grecia 3
JO - Giordania 3
PY - Paraguay 3
TH - Thailandia 3
UY - Uruguay 3
UZ - Uzbekistan 3
CH - Svizzera 2
HN - Honduras 2
MD - Moldavia 2
OM - Oman 2
PE - Perù 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CL - Cile 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GP - Guadalupe 1
HR - Croazia 1
JM - Giamaica 1
KE - Kenya 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MT - Malta 1
NO - Norvegia 1
NP - Nepal 1
PH - Filippine 1
RS - Serbia 1
Totale 4.927
Salva come PNG Salva come JPEG
Città #
Ashburn 318
Singapore 316
Dallas 315
Dublin 190
Parma 180
Chandler 159
Hong Kong 119
Santa Clara 99
Boardman 98
Munich 77
Beijing 65
New York 60
Ann Arbor 55
Vienna 53
Bologna 51
Los Angeles 51
Shanghai 47
Milan 44
Johannesburg 38
Ho Chi Minh City 36
Hefei 35
Dearborn 30
Helsinki 25
Moscow 22
Nanjing 22
Hanoi 21
Bremen 20
Turku 20
Amsterdam 19
Brussels 19
Verona 19
Abidjan 18
São Paulo 17
Buffalo 16
Princeton 16
Frankfurt am Main 15
Izmir 15
Reggio Emilia 15
Modena 14
Warsaw 14
Atlanta 13
Rome 13
Tokyo 13
Toronto 13
Montreal 12
Nanchang 12
Brooklyn 11
London 11
Nuremberg 11
Rio Saliceto 11
Seoul 11
Chicago 10
Columbus 10
West Jordan 10
Brno 9
Carpi 9
Chongqing 9
Denver 9
Olomouc 9
Redondo Beach 9
The Dalles 9
Trento 9
Fremont 8
Guangzhou 8
Hebei 8
Marseille 8
Pune 8
Rio de Janeiro 8
Seattle 8
Wilmington 8
Baghdad 7
Brescia 7
Houston 7
Poplar 7
Jinan 6
Lahore 6
Mexico City 6
Zhengzhou 6
Bengaluru 5
Bolzano 5
Chennai 5
Curitiba 5
Des Moines 5
Florence 5
Guarulhos 5
Guayaquil 5
Haiphong 5
Kunming 5
Kyiv 5
Malo 5
Querétaro 5
Sector 6 5
Shenyang 5
Stockholm 5
Assago 4
Baku 4
Belo Horizonte 4
Changsha 4
Charlotte 4
Düsseldorf 4
Totale 3.216
Salva come PNG Salva come JPEG
Nome #
Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients 182
1328P Dynamic blood immune-inflammatory and radiomic profiling to decode distinct patterns of acquired resistance to immunotherapy in NSCLC patients 177
238P Exploring blood immune cell dynamics to unravel the immunomodulatory effect of radiotherapy in NSCLC patients undergoing immune checkpoint inhibitors 176
227P Sexual dimorphism in immune profile of early and advanced NSCLC 173
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemia 172
MESENCHYMAL STROMAL CELLS ISOLATED FROM DEFINED NSCLC CONTEXTURES REPRODUCE THE IMMUNE SIGNATURE OF THE PARENTAL MICROENVIRONMENT 169
Low PD-1 expression in Cytotoxic CD8+ Tumor infiltrating Lymphocytes Confers an Immune Privileged Tissue Microenvironment in NSCLC with a Prognostic and Predictive Value 153
INTEGRATION OF TISSUE PD-1/PD-L1 IMMUNE CHECKPOINT WITH COMPUTED TOMOGRAPHY (CT) BASED TEXTURE ANALYSIS EXHIBITS HIGH PROGNOSTIC IMPACE ON SURGICALLY RESECTED NON SMALL CELL LUNG CANCER (NSCLC) 149
189P The parallel interrogation of tissue and peripheral blood immune features unveils a bidirectional crosstalk with clinical impact on resected NSCLC 147
Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer 147
LONGITUDINAL MONITORING OF RADIOMIC AND BLOOD IMMUNE-INFLAMMATORY DESCRIPTORS AS A NON-INVASIVE APPROACH TO PREDICT ICI EFFICACY IN ADVANCED NSCLC PATIENTS 139
BLOOD AND LYMPHATIC VESSELS CONSTITUTE AN ESSENTIAL COMPONENT OF THE IMMUNE MICROENVIRONMENT AND ITS IMPACT ON NON SMALL CELL LUNG CANCER (NSCLC) CLINICAL OUTCOME 138
In Vitro Biological and Functional Properties of Human Endothelial Cells from Different Sources Exposed to Different Beta-Blockers 138
Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer 137
Assessment of Cardiac Patches Suitability for Tissue Engineering 137
Isolation and characterization of human lung lymphatic endothelial cells 136
Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer 134
Lung mesenchymal cells function as an inductive microenvironment for human lung cancer propagating cells† 132
2315P Clinical and blood immune-inflammatory profiling to decode different patterns of acquired resistance in immunotherapy treated NSCLC patients 129
Integrated MRI–Immune–Genomic Features Enclose a Risk Stratification Model in Patients Affected by Glioblastoma 124
Identification of the Atypical Protein Kinase WNK1 As a New Target in T-Cell Acute Lymphoblastic Leukemia 119
Structural and Functional Characterization of the Hemolymphangiogenic Microenvironment in Lung Cancer 119
Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC 118
Dynamic evolution of blood immune-inflammatory descriptors in advanced non-small cell lung cancer undergoing first-line immunotherapy-based regimens 113
Differential Pattern of Myocardial Remodelling in Genetically Determined and Load- Dependent Hypertrophy in Humans 110
Orthogonal Proteogenomic Approaches Identify the Druggable PA2G4-MYC Axis in 3q26 AML 108
IMPACT OF THE TISSUE DISTRIBUTION OF SUBPOPULATIONS OF TILS AND PD-L1 EXPRESSION ON THE CLINICAL OUTCOME OF NSCLC 105
1061P Static and dynamic tracking of radiomic and immunophenotypic features predicts the benefit of immune checkpoint inhibitors in advanced NSCLC 104
CAD204520 Targets NOTCH1 PEST Domain Mutations in Lymphoproliferative Disorders 103
P1.15-04 Dynamic Profiling of Blood Immunophenotypes and Radiomic Features to Predict Immunotherapy Response in Advanced Non-small Cell Lung Cancer 99
5P Blood immune-inflammatory dynamic unveils distinctive irAE features in ICI treated NSCLC 98
Β-blockers activate autophagy on infantile hemangioma-derived endothelial cells in vitro 97
Differential Tumorigenic Properties of Mesenchymal Cells From Neoplastic and Non-Neoplastic Human Lung in NSCLC 97
The Atypical Protein Kinase WNK1 Controls Leukemia Progression in TAL/LMO T-Cell Acute Lymphoblastic Leukemia 95
Orthogonal proteogenomic analysis identifies the druggable PA2G4-MYC axis in 3q26 AML 89
Genetics of Darier’s Disease: New Insights into Pathogenic Mechanisms 84
Advanced CT imaging features reflect distinct tissue immune profiles and exhibit high prognostic impact on NSCLC 82
Divergent PD-1 expression in tissue and circulating CD8 lymphocytes defines an immune profile predictive of the response to nivolumab in advanced NSCLC 77
Deciphering the different patterns of acquired resistance in immunotherapy treated NSCLC patients through an integrated clinical and blood immuneinflammatory profiling 72
CD26 is differentially expressed throughout the life cycle of infantile hemangiomas and characterizes the proliferative phase 50
Deciphering multifaceted connections between NOTCH1 and SERCA2 proteins in the Darier's disease: a paradigmatic molecular network in the pathogenesis of a Mendelian genodermatosis 29
Longitudinal blood immune-inflammatory and radiomic profiling to decode different patterns acquired resistance to immunotherapy in patients with NSCLC 28
EHMT2/G9A drives the epigenetic regulation of glucose metabolism in T-cell Acute lymphoblastic leukemia 24
Totale 5.009
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.470
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.470
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202173 0 0 0 0 0 12 1 4 14 7 29 6
2021/202291 8 5 2 6 1 4 15 7 2 5 4 32
2022/2023767 58 70 40 71 110 72 26 45 214 7 39 15
2023/2024510 24 22 21 26 50 72 83 20 31 48 29 84
2024/20251.247 63 64 92 112 113 82 105 74 116 102 109 215
2025/20261.959 288 227 547 361 385 151 0 0 0 0 0 0
Totale 5.009